Symptoms comparison of common upper respiratory disorders including the common cold, influenza, pharyngitis, allergic rhinitis, and the novel COVID-19.
Based on 12 studies, the pooled analysis showed no association between allergic rhinitis and risk of rheumatoid arthritis.
Children with more severe forms of allergic rhinitis had a higher risk for current asthma and bronchial hyperreactivity compared with children with milder forms.
Patients who received olopatadine/mometasone either once or twice daily experienced significant improvements in their instantaneous Total Nasal Symptom Scores compared with placebo.
GSP301 treatment was associated with a significant improvement in reflective and instantaneous Total Nasal Symptom Scores compared with placebo.
Patients who received a fixed-dose combination nasal spray showed significantly improved Physician-assessed Nasal Symptom Scores compared with those who received placebo.
The majority of study participants had rhinitis at baseline, including perennial allergic rhinitis with seasonal exacerbations, which is the most severe phenotype.
Childhood non-atopic rhinitis is associated with an increased risk for adult asthma.
Fluticasone Propionate Nasal Spray is a corticosteroid indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adults and pediatric patients aged 4 years and older.